![Steven F. Dowdy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven F. Dowdy
Corporate Officer/Principal bij University of California San Diego
Actieve functies van Steven F. Dowdy
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of California San Diego | Corporate Officer/Principal | - | - |
Loopbaan van Steven F. Dowdy
Eerdere bekende functies van Steven F. Dowdy
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Traversa Therapeutics, Inc.
![]() Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies. The Company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies for use by RNAi therapeutic companies in targeting a wide variety of acute, chronic and infectious human diseases. Traversa is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of Leukemia and Glioblastoma. The Company was founded in La Jolla, California in mid-2006, and has secured worldwide exclusive licenses to intellectual property developed during the past five years by Steven F. Dowdy, Ph.D., and his research group at the Howard Hughes Medical Institute and the University of California San Diego relating to siRNA delivery technology and induction of RNA Interference (RNAi). | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | 19-12-2012 |
Oprichter | 05-08-2009 | 19-12-2012 | |
Solstice Biologics LLC
![]() Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 01-01-2012 | - |
Oprichter | 01-01-2012 | - |
Opleiding van Steven F. Dowdy
University of California, Irvine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Traversa Therapeutics, Inc.
![]() Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies. The Company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies for use by RNAi therapeutic companies in targeting a wide variety of acute, chronic and infectious human diseases. Traversa is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of Leukemia and Glioblastoma. The Company was founded in La Jolla, California in mid-2006, and has secured worldwide exclusive licenses to intellectual property developed during the past five years by Steven F. Dowdy, Ph.D., and his research group at the Howard Hughes Medical Institute and the University of California San Diego relating to siRNA delivery technology and induction of RNA Interference (RNAi). | Commercial Services |
Solstice Biologics LLC
![]() Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Steven F. Dowdy
- Ervaring